ENTITY

Rain Oncology (RAIN US)

Analysis

Health Care • United States

Rain Oncology Inc. operates as a clinical stage biotechnology company. The Company develops and produces biomarker-driven small molecule therapeutics for patients with cancer and other related diseases. Rain Oncology serves customers worldwide.

Refresh

Focused

No publications yet

There aren’t any buy-side reports right now

Back to "All"

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00